ArticleBritish journal of pharmacology2019

Repurposing drugs targeting the P2X7 receptor to limit hyperinflammation and disease during influenza virus infection.

Sarah Rosli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.